EL GLAOUI, Guillaume,EL GLAOUI, Mehdi,PERRIN, Philippe,DROUPY, Stéphane,AGATHON-MERIAU, Véronique
申请号：
AU2019237228
公开号：
AU2019237228A1
申请日:
2019.03.22
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to the use of a composition in a non-hormonal contraception method for a male subject, comprising administering an alpha-1-adrenoreceptor antagonist； wherein the contraception method includes a once daily administration of said composition at about the same time each day, triggering a continuous reversible aspermia, azoospermia, or severe oligozoospermia in the male subject, and wherein after an initial period of at least two consecutive days, the contraception is not impaired by a delay of the subsequent once daily intake. This invention also relates to the packaging comprising 7, 14, 28, 56, 84, or 168 to 365 unit doses； or 10, 20, 30, 60, 90, or 180 to 360 single doses of the composition to be implemented according to the present invention.
